Choose timezone
Your profile timezone:
Hadron Therapy Workshop: status and perspectives, plans for next generation facilities 18-19 October 2024
→
Europe/Zurich
Zoom
Zoom
https://cern.zoom.us/j/66191778491?pwd=trGT2SYZAbOE5ZpaIwmzV5oA8UZbXQ.1
Description
Webcast Link: https://webcast.cern.ch/view/wyxgrrnoendlmwbp/1431627
Scientific Assistants: Elpida Theodoridou (Uni Malta/DKFZ) chair, Nermine Muradi (Uni Tetova) chair, Alexandros Puckett Anastasiou (Uni Patra), Athanasios Athanasiou (AUTh), Christina Litou (AUTh), Dafni Giannakeri (AUTh), Effrosyni Chatzivasiloglou (AUTh), George Ntinas (AUTh), Maria Eleni Bozika (AUTh), Maria Vagianni (AUTh), Emina Huko (UNSA), Feriha Babic (UNSA), Naida Ustavdic (UNSA), Medina Dugonjic (UNSA), Danis Bradaric (UNSA).
-
-
SESSION 1 - HADRON THERAPY OVERVIEW¶
Moderators: Manjit Dosanjh, Yiota Foka
-
1
Participants registration¶
-
2
Welcome Addresses¶
Maria Bigaki (IAEA CP, Papageorgiou), Michail Karaviotis ( Papageorgiou),
Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO),
Panagiotis Bamidis (AUTH,/AHEPA, ELEVIT) -
3
Historic and scientific evolution of Hadron Therapy¶Speakers: Ugo Amaldi (TERA Foundation (IT)), Sandro Rossi (CNAO)
- 4
-
5
Radiobiology of Hadron Therapy¶Speaker: Angelica Facoetti (CNAO)
-
6
HITRIplus project, its impact on boosting research in South East Europe and future perspectives¶Speaker: Sanja Damjanovic (SEEIIST Association (CH) / GSI)
-
7
Building capacity through the IAEA programs¶Speaker: Sotirios Charisopoulos (IAEA)
-
10:55
Coffee Break
-
1
-
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES¶
Moderator: Roberto Orecchia
-
8
Hadron Therapy : from pioneering times towards the future¶Speaker: Manjit Dosanjh (University of Oxford (GB))
-
9
SEEIIST facility design and alternatives¶Speaker: Maurizio Vretenar (CERN)
-
10
CERN as an example of large scale infrastructure¶Speaker: Emmanuel Tsesmelis (CERN)
-
11
Status and vision of the SEEIIST project¶Speaker: Leandar Litov (University of Sofia - St. Kliment Ohridski (BG))
- 12
-
13
Round table – SEEIIST towards to the Future¶
Moderators: Sotirios Charisopoulos (IAEA), Sandro Rossi (HITRIplus, CNAO)
Panelists: Maurizio Vretenar (CERN), Semi Harrabi (HIT)
Contributions: Introduction, cancer incidence in SEE Mimoza Ristova (Uni Skopje) -
13:45
Lunch Break
-
8
-
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE¶
Moderator: Angelica Facoetti
-
14
Hadron Therapy at GSI - where we come from, where we go¶Speaker: Konrad Lehmann (GSI)
-
15
The HIT facility, technology, clinical applications and research: novel approaches in particle therapy¶Speaker: Andrea Mairani (HIT)
-
16
The Krakow Hadron Therapy facility, lessons learnt¶Speaker: Pawel Olko (IFJ - PAN)
- 17
-
16:30
Coffee Break
-
14
-
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES¶
Moderator: Laura Vallow
-
18
Accelerator and beam physics developments for medical and societal applications at CERN¶Speaker: Alessandra Lombardi (CERN)
-
19
Innovative gantry designs: Superconducting magnets for advanced gantry¶Speaker: Ernesto De Matteis (INFN)
-
20
Innovative gantry designs-continued¶Speaker: Ariel Haziot (CERN)
-
21
Optimisation for pre-injectors for hadron therapy-AM¶Speaker: Aristeidis Mamaras (Aristotle University of Thessaloniki / CERN)
-
22
An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina¶Speakers: Amer Ajanovic (CERN/UNSA), Danis Bradaric (UNSA), Medina Dugonjic (UNSA), Naida Ustavdic (UNSA)
-
23
Development of the first table-top X-ray FLASH system¶Speakers: Ms ELPIDA THEODORIDOU (DKFZ / Uni Malta), Joao Seco (DKFZ)
- 24
- 25
-
18
-
-
-
Session 5 – INDICATIONS FOR HADRON THERAPY: Indications and clinical applications of HT¶
Moderators: Arnold Pompos, Joao Seco
-
26
Chordoma treatments at CNAO¶Speaker: Maria Rosaria Fiore (CNAO)
-
27
Sarcoma treatments in Greece¶Speaker: Tasos Kyriazoglou (Attikon University Hospital)
-
28
Radiosurgery for Skullbase Meningiom¶Speaker: Christos Boskos (ST. LUKE'S)
-
29
SRS Treatment Planning for Endocranial Tumor¶Speaker: Anna Makridou
-
30
Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability¶Speaker: Michael Story (Mayo Clinic)
- 31
-
11:05
Coffee Break
-
26
-
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY¶Convener: Sandro Rossi (Fondazione CNAO)
-
32
Hadrontherapy and EU clinical networks: status and perspectives¶Speaker: Lisa Licitra (CNAO, Uni Milan)
-
33
Costs of hadrontherapy, the ABC analysis applied to operations in CNAO¶Speaker: Maria Vittoria Livraga (CNAO)
-
34
Caring for cancer patients: the CNAO social approach¶Speaker: Silvia Meneghello (CNAO)
-
35
The role of citizens in innovating health¶Speakers: Katerina Zourou (Web2Learn), Stefania Oikonomou (Web2Learn)
-
36
The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level¶Speaker: Alkinoos Athanasiou (AUTH, ELEVIT)
-
37
Challenges and Opportunities in the Patient's Pathway to Access¶Speaker: Menia Koukougianni (NGO KARKINAKI)
-
38
Empowering patient advocacy and cancer prevention¶Speaker: Panagiotis Bamidis (AUTH/AHEPA, ELEVIT)
- 39
-
13:40
Lunch Break
-
32
-
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY¶
Moderators: Antonio Capizzello, Emmanouel Chatzipantelis, Eugenia Papakonstantinou, Semi Harrabi
-
40
Carbon Programme in MedAustron¶Speaker: Piero Fossati (MedAustron)
-
41
Pediatric Treatments in MedAustron¶Speaker: Carola Lütgendorf-Caucig (MedAustron)
-
42
Hadron therapy state-of-the art in pediatric oncology-clinical aspects¶Speaker: Sabina Vennarini (CNAO)
-
43
Treatment planning for pediatric cancer tumour treatments¶Speaker: Alfredo Mirandola (CNAO)
-
44
Pediatric brain tumour surgery : where do we stand?¶Speaker: Nikos Foroglou (AUTH/AHEPA)
-
45
Role of surgery in pediatric soft tissue sarcoma¶Speaker: Aikaterini Tzantzaroudi (Hippokration Hospital)
-
16:30
Coffee Break
-
46
Panel discussion: Paediatric Oncology in Greece¶
-
47
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA¶Speaker: Emmanouel Chatzipantelis (AUTH/AHEPA)
-
48
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital¶Speaker: Evgenia Papakonstantinou (Hippokrateio Hospital)
-
49
Pediatric patients commonly referred for external beam Radiotherapy¶Speakers: Antonio Capizzello (AUTH / AHEPA), Eftychia Tataridou (Theageneio Hospital)
-
50
The spectrum of pediatric patients referred for Protontherapy¶Speaker: Barbara Rombi (APSS - TRENTO)
-
51
Radiation treatment plan for pediatric cancer: a clinical view¶Speaker: George Giakoumetis (AUTH/AHEPA)
- 52
-
40
-
